ESC 365 - Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients

Back

ESC Premium Access

Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients

Session: Poster Session 2 - Hypertension treatment old and new

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor A. Farcas (Cluj Napoca, RO)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Anca Daniela Farcas

University of Medicine and Pharmacy of Cluj Napoca, Cluj Napoca (Romania)

0 follower

9 more presentations in this session

Rates of adherence to modern antihypertensive drugs in resistant hypertension

Speaker: Doctor E. Kocianova (Olomouc, CZ)

Access

Abstract

Slides

Non-steroid anti-inflammatory drug consumption decrease antihypertensive treatment efficacy in postenopausal women

Speaker: Professor N. Izmozherova (Yekaterinburg, RU)

Access

Abstract

Long-term treatment with LCZ696 (sacubitril/valsartan) improves cardiac and renal function in stroke-prone spontaneously hypertensive rats

Speaker: Professor Y. Takeda (Uchinada, JP)

Access

Abstract

Slides

Effect of perindopril/indapamide/amlodipine fixed-dose combination on peripheral and central hemodynamics and vascular wall stiffness parameters in patients with uncontrolled hypertension

Speaker: Doctor T. Netchessova (Minsk, BY)

Access

Abstract

Slides

CHINA STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive Patients: A one-year registry (CHINA STATUS III)

Speaker: Mr Z. Du (Beijing, CN)

Access

Abstract

Slides

Access the full session

Poster Session 2 - Hypertension treatment old and new

Speakers: Doctor A. Farcas, Doctor E. Kocianova, Professor N. Izmozherova, Professor Y. Takeda, Doctor T. Netchessova...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources